Therapie der Sialorrhoe mit Botulinumtoxin – ein Update

Jost, Wolfgang H.; Bäumer, Tobias; Berweck, Steffen; Laskawi, Rainer; Spittau, Bjoern; Steffen, Armin und Winterholler, Martin (2022): Therapie der Sialorrhoe mit Botulinumtoxin – ein Update. In: Fortschritte der Neurologie - Psychiatrie, Bd. 90, Nr. 5: S. 222-232

Abstract

The most important salivary glands are the paired parotid and submandibular glands. Adults produce 1 to 1.5 liters of saliva which are then regularly swallowed. When the act of swallowing is disturbed, salivation occurs. More rarely, the cause can be found in increased saliva production, for example, when caused through medication. Sialorrhea impairs the quality of life substantially and is frequently often socially stigmatizing. Therapy includes conservative measures such as functional dysphagia therapy, oral ortransdermal application of anticholinergics, as well as, in selected cases, radiation and surgical measures. Over the last 20 years, local injection of botulinum toxin has been successfully applied in the treatment of this condition. With approval of incobotulinumtoxinA toxin for children and adults, this procedure will become the therapy of choice for chronic sialorrhea. The results of the phase Ill registration trials have demonstrated high efficacy and good safety of the injection treatment in both children and adults.

• Dokumententyp: Zeitschriftenartikel
• Fakultät: Medizin
• Themengebiete: 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit
• ISSN: 0720-4299
• Sprache: Deutsch